These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1346387)

  • 1. Estimating the stability of the proposed imprinted state of the fragile-X mutation when transmitted by females.
    Follette PJ; Laird CD
    Hum Genet; 1992 Jan; 88(3):335-43. PubMed ID: 1346387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible erasure of the imprint on a fragile X chromosome when transmitted by a male.
    Laird CD
    Am J Med Genet; 1991; 38(2-3):391-5. PubMed ID: 2018078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two progenitor cells for human oogonia inferred from pedigree data and the X-inactivation imprinting model of the fragile-X syndrome.
    Laird CD; Lamb MM; Thorne JL
    Am J Hum Genet; 1990 Apr; 46(4):696-719. PubMed ID: 1969225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population genetic consequences of the fragile-X syndrome, based on the X-inactivation imprinting model.
    Sved JA; Laird CD
    Am J Hum Genet; 1990 Mar; 46(3):443-51. PubMed ID: 2309697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X chromosome imprinting in fragile X syndrome.
    Yu WD; Wenger SL; Steele MW
    Hum Genet; 1990 Oct; 85(6):590-4. PubMed ID: 2227950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of mutations in the gene FMR-1 segregating in fragile X families.
    Steinbach P; Wöhrle D; Tariverdian G; Kennerknecht I; Barbi G; Edlinger H; Enders H; Götz-Sothmann M; Heilbronner H; Hosenfeld D
    Hum Genet; 1993 Nov; 92(5):491-8. PubMed ID: 7902319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the fragile-X in the "premutated"/"non-imprinted" state.
    Bilas R; Wilhelm D; Schwinger E; Chudley AE; Fryns JP; Howard-Peebles PN; Schinzel A; Van Roy B; Webb T
    Genet Couns; 1992; 3(4):179-81. PubMed ID: 1361753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fragile X family with high penetrance in females: risk heterogeneity?
    Martínez F; Badía L; Prieto F
    Clin Genet; 1992 Jul; 42(1):22-6. PubMed ID: 1355415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposed mechanism of inheritance and expression of the human fragile-X syndrome of mental retardation.
    Laird CD
    Genetics; 1987 Nov; 117(3):587-99. PubMed ID: 3692144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of a family with a fragile site of the X chromosome at Xq27-28 without mental retardation.
    Voelckel MA; Philip N; Piquet C; Pellissier MC; Oberlé I; Birg F; Mattei MG; Mattei JF
    Hum Genet; 1989 Mar; 81(4):353-7. PubMed ID: 2564838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile-X mutation proposed to block complete reactivation in females of an inactive X chromosome.
    Laird CD
    Am J Med Genet; 1988; 30(1-2):693-6. PubMed ID: 3177479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation.
    Rousseau F; Heitz D; Biancalana V; Blumenfeld S; Kretz C; Boué J; Tommerup N; Van Der Hagen C; DeLozier-Blanchet C; Croquette MF
    N Engl J Med; 1991 Dec; 325(24):1673-81. PubMed ID: 1944467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal pattern detected in fragile-X patients by pulsed-field gel electrophoresis.
    Vincent A; Heitz D; Petit C; Kretz C; Oberlé I; Mandel JL
    Nature; 1991 Feb; 349(6310):624-6. PubMed ID: 1672039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and expression of the fragile X syndrome.
    Brown WT; Jenkins EC; Gross AC; Chan CB; Wisniewski K; Cohen IL; Miezejeski CM
    Ups J Med Sci Suppl; 1987; 44():137-54. PubMed ID: 2895523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct DNA testing for fragile X syndrome.
    Ramos FJ; Eunpu DL; Finucane B; Pfendner EG
    Am J Dis Child; 1993 Nov; 147(11):1231-5. PubMed ID: 7901988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The marker (X) syndrome: a cytogenetic and genetic analysis.
    Sherman SL; Morton NE; Jacobs PA; Turner G
    Ann Hum Genet; 1984 Jan; 48(1):21-37. PubMed ID: 6712153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile X expression and X inactivation. II. The fragile site at Xq27.3 has a basic function in the pathogenesis of fragile X-linked mental retardation.
    Wöhrle D; Steinbach P
    Hum Genet; 1991 Aug; 87(4):421-4. PubMed ID: 1715307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FMR1 gene deletion/reversion: a pitfall of fragile X carrier testing.
    Gasteiger M; Grasbon-Frodl E; Neitzel B; Kooy F; Holinski-Feder E
    Genet Test; 2003; 7(4):303-8. PubMed ID: 15000806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
    Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
    JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage and genetic counselling for the fragile X using DNA probes 52A, F9, DX13, and ST14.
    Mulley JC; Gedeon AK; Thorn KA; Bates LJ; Sutherland GR
    Am J Med Genet; 1987 Jun; 27(2):435-48. PubMed ID: 2886048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.